FDA NDC Directory · JSON-LD · Markdown

Cyclobenzaprine Hydrochloride

NDC 33342-273 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerMacleods Pharmaceuticals Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA207314
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsCYCLOBENZAPRINE HYDROCHLORIDE (30 mg/1)
Marketing started20240722
Package count2

External sources

Source: openFDA. Public-domain (CC0).